{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:19:47Z","timestamp":1648779587030},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.pep.2008.07.002","type":"journal-article","created":{"date-parts":[[2008,7,19]],"date-time":"2008-07-19T08:54:16Z","timestamp":1216457656000},"page":"15-20","source":"Crossref","is-referenced-by-count":4,"title":["Improvement in soluble expression levels of a diabody by exchanging expression vectors"],"prefix":"10.1016","volume":"62","author":[{"given":"Fang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenguo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunzheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2008.07.002_bib1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tibtech.2004.03.006","article-title":"A revival of bispecific antibodies","volume":"22","author":"Kufer","year":"2004","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.pep.2008.07.002_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0169-409X(02)00178-3","article-title":"Bispecific antibody conjugates in therapeutics","volume":"55","author":"Cao","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pep.2008.07.002_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1745-7254.2005.00008.x","article-title":"Recombinant bispecific antibodies for cancer therapy","volume":"26","author":"Kontermann","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.pep.2008.07.002_bib4","doi-asserted-by":"crossref","first-page":"53907","DOI":"10.1074\/jbc.M407888200","article-title":"Bispecific minibodies targeting HER2\/neu and CD16 exhibit improved tumor lysis when placed in a divalent tumor antigen binding format","volume":"279","author":"Shahied","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pep.2008.07.002_bib5","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1073\/pnas.90.14.6444","article-title":"\u201cDiabodies\u201d: small bivalent and bispecific antibody fragments","volume":"90","author":"Holliger","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pep.2008.07.002_bib6","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/bjc.1998.233","article-title":"Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2\/neu","volume":"77","author":"Adams","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.pep.2008.07.002_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1389-0344(01)00083-1","article-title":"Bispecific and bifunctional single chain recombinant antibodies","volume":"18","author":"Kriangkum","year":"2001","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.pep.2008.07.002_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/1380-2933(95)00027-5","volume":"2","author":"Wu","year":"1996","journal-title":"Immunotechnology"},{"key":"10.1016\/j.pep.2008.07.002_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/35101072","article-title":"Improving the efficacy of antibody-based cancer therapies","volume":"1","author":"Carter","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.pep.2008.07.002_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev.med.54.101601.152442","article-title":"Monoclonal antibody therapy for cancer","volume":"54","author":"von Mehren","year":"2003","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.pep.2008.07.002_bib11","first-page":"233","article-title":"Recent advances in the generation of bispecific antibodies for tumor immunotherapy","volume":"7","author":"Kipriyanov","year":"2004","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.pep.2008.07.002_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.leu.2403267","article-title":"Efficient inhibition of multidrug-resistant human tumors with a recombinant bispecific anti-P-glycoprotein\u00d7anti-CD3 diabody","volume":"18","author":"Gao","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.pep.2008.07.002_bib13","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1158\/0008-5472.CAN-04-2637","article-title":"Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-\/CD3-bispecific antibody construct","volume":"65","author":"Schlereth","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.pep.2008.07.002_bib14","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1158\/1078-0432.CCR-06-0059","article-title":"Humanization of the bispecific epidermal growth factor receptor CD3 diabody and its efficacy as a potential clinical reagent","volume":"12","author":"Asano","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pep.2008.07.002_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00262-007-0348-6","article-title":"A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells","volume":"57","author":"B\u00fchler","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.pep.2008.07.002_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/(SICI)1097-0215(19980831)77:5<763::AID-IJC16>3.0.CO;2-2","article-title":"Bispecific CD3\u00d7CD19 diabody for T cell-mediated lysis of malignant human B cells","volume":"77","author":"Kipriyanov","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pep.2008.07.002_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4049\/jimmunol.169.1.137","article-title":"Synergistic antitumor effect of bispecific CD19\u00d7CD3 and CD19\u00d7CD16 diabodies in a preclinical model of non-Hodgkin\u2019s lymphoma","volume":"169","author":"Kipriyanov","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.pep.2008.07.002_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s002620050189","article-title":"CD8 T cell activation after intravenous administration of CD3\u00d7CD19 bispecific antibody in patients with non-Hodgkin lymphoma","volume":"40","author":"de Gast","year":"1995","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.pep.2008.07.002_bib19","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1182\/blood.V85.11.3208.bloodjournal85113208","article-title":"The efficacy of CD3\u00d7CD19 bispecific monoclonal antibody (BsAb) in a clonogenic assay: the effect of repeated addition of BsAb and interleukin-2","volume":"85","author":"Haagen","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.pep.2008.07.002_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/jmbi.1999.3156","article-title":"Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics","volume":"293","author":"Kipriyanov","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pep.2008.07.002_bib21","first-page":"1704","article-title":"Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3\u00d7CD19 bispecific antibodies, CD28 monospecific antibodies and autologous T cells","volume":"57","author":"Bohlen","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.pep.2008.07.002_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s002620050432","article-title":"CD3\u00d7CD19 bispecific antibodies and CD28 costimulation for locoregional treatment of low malignancy non-Hodgkin\u2019s lymphoma","volume":"45","author":"Manzke","year":"1997","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.pep.2008.07.002_bib23","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1182\/blood.V92.12.4750","article-title":"Immunotherapy of B-cell lymphoma with CD3\u00d719 bispecific antibodies: costimulation via CD28 prevents \u201cveto\u201d apoptosis of antibody targeted cytotoxic T cells","volume":"92","author":"Daniel","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.pep.2008.07.002_bib24","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1182\/blood.V95.6.2098","article-title":"A recombinant bispecific single-chain antibody, CD19\u00d7CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes","volume":"95","author":"L\u00f6ffler","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pep.2008.07.002_bib25","first-page":"4336","article-title":"Cure of Burkitt\u2019s lymphoma in severe combined immunodeficiency mice by T Cells, tetravalent CD3\u00d7CD19 tandem diabody, and CD28 costimulation","volume":"60","author":"Cochlovius","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.pep.2008.07.002_bib26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4049\/jimmunol.165.2.888","article-title":"Treatment of human B cell lymphoma xenografts with a CD3\u00d7CD19 diabody and T cells","volume":"165","author":"Cochlovius","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.pep.2008.07.002_bib27","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.4049\/jimmunol.173.10.6009","article-title":"The role of B cell-mediated T cell costimulation in the efficacy of the T cell retargeting bispecific antibody BIS20\u00d73","volume":"173","author":"Stel","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.pep.2008.07.002_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood.V71.1.13.13","article-title":"Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins","volume":"71","author":"Uckun","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.pep.2008.07.002_bib29","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V81.6.1549.1549","article-title":"Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines: an immunofluorescence and immunoelectron microscopy study","volume":"81","author":"Pulczynski","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.pep.2008.07.002_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/sj.leu.2402320","article-title":"Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies","volume":"16","author":"Ma","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.pep.2008.07.002_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3835(01)00758-3","article-title":"Efficient inhibition of human B-cell lymphoma xenografts with an anti-CD20\u00d7anti-CD3 bispecific diabody","volume":"177","author":"Xiong","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.pep.2008.07.002_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pep.2005.03.030","article-title":"Increase of soluble expression in Escherichia coli cytoplasm by a protein disulfide isomerase gene fusion system","volume":"44","author":"Liu","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.pep.2008.07.002_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nbt0498-376","article-title":"Selection for a periplasmic factor improving phage display and functional periplasmic expression","volume":"16","author":"Bothmann","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pep.2008.07.002_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/protein\/gzh039","article-title":"Effect of linker sequences between the antibody variable domains on the formation stability and biological activity of a bispecific tandem diabody","volume":"17","author":"Le Gall","year":"2004","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.pep.2008.07.002_bib35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/protein\/13.8.583","article-title":"Construction of a diabody (small recombinant bispecific antibody) using a refolding system","volume":"13","author":"Takemura","year":"2000","journal-title":"Protein Eng."},{"key":"10.1016\/j.pep.2008.07.002_bib36","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/oxfordjournals.jbchem.a003303","article-title":"Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment","volume":"132","author":"Asano","year":"2002","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.1016\/j.pep.2008.07.002_bib37","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pep.2008.07.002_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/bst0300507","article-title":"Bispecific antibodies targeting cancer cells","volume":"30","author":"Peipp","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.pep.2008.07.002_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pep.2005.03.018","article-title":"Purification and in vitro characterization of the maltose-binding protein of the plant pathogen Xanthomonas citri","volume":"43","author":"Balan","year":"2005","journal-title":"Protein Expr. Purif."}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592808001782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592808001782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T04:06:32Z","timestamp":1588824392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592808001782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S1046592808001782"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2008.07.002","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}